Clinical Validity of CTS5 for Estimating Risk of Late Recurrence in Unselected, Non-Trial Patients with Early ER+ Breast Cancer.Juliet Richman,Alistair E. Ring,Mitchell Dowsett,Ivana SestakJournal of clinical oncology（2019）引用 10|浏览21AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
